HealthDay News – The National Institutes of Health have launched a new database to collect information and biospecies from people who have experienced neurological problems related to severe coronavirus-2 infection with acute respiratory syndrome.
The new COVID-19 Neuro Databank / Biobank (NeuroCOVID) is managed by NYU Langone Health in New York City. Healthcare providers are requested to use the web-based data portal to submit unidentified information to the database along with relevant bio-species collected during research studies or from previous clinical procedures and tests.
The database collects information on COVID-19-related neurological symptoms, complications and results, as well as COVID-19 effects on pre-existing neurological diseases. Researchers can access NeuroCOVID to study the prevention, management, and treatment of neurological complications related to COVID-19. Hopefully the database will provide insight into the effects of COVID-19 on the nervous system, as well as the frequency or rarity of such complications.
“The effects of the virus and the body’s response to COVID-19 infection on the brain, spinal cord, nerves and muscles can be particularly devastating and help the disability persist after the virus is cleared,” said Barbara Karp, MD . Program director at the National Institute for Neurological Disorders and Stroke said in a statement. “There is an urgent need to understand the neurological problems associated with COVID-19, which not infrequently include headaches, fatigue, cognitive difficulties, stroke, pain and sleep disorders, and some very rare complications of serious infections.”
COVID19 General Neurology